The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Significance of alterations in DNA damage repair (DDR) genes in advanced biliary cancers (ABCs) treated with second-line active-symptom-control (ASC) alone or ASC with oxaliplatin/5-FU chemotherapy (ASC+FOLFOX) in the randomised phase III, multicentre, open-label ABC-06 trial.
 
Angela Lamarca
Consulting or Advisory Role - Albireo Pharma; AstraZeneca/MedImmune; Boston Scientific; Eisai; Ipsen; Nutricia; Nutricia (I); QED Therapeutics; Roche; SERVIER
Speakers' Bureau - Advanced Accelerator Applications; AstraZeneca/MedImmune; Eisai; Incyte; Ipsen; Ipsen (I); Merck; Novartis (I); Pfizer; Pfizer (I); QED Therapeutics; SERVIER
Research Funding - Ipsen; Ipsen (I); Roche
Travel, Accommodations, Expenses - Abbott Nutrition; Advanced Accelerator Applications; Bayer; Celgene; Delcath Systems; Ipsen; Ipsen (I); Mylan; NanoString Technologies (I); Novartis; Pfizer; Sirtex Medical
 
Daniel H. Palmer
Consulting or Advisory Role - AstraZeneca; BMS (Inst); Boston Scientific; Eisai; MSD; Roche; Sirtex Medical; Viatris
Research Funding - AstraZeneca; Bayer; BMS; Nucana; Sirtex Medical
 
Harpreet Singh Wasan
Honoraria - Array BioPharma; Celgene; ERYTECH Pharma; Incyte; Merck KGaA; Roche/Genentech; Servier; Sirtex Medical; Zymeworks
Consulting or Advisory Role - Bayer; ERYTECH Pharma; Incyte; Pfizer; Pierre Fabre; Roche Pharma AG; Shire; Sirtex medical
Speakers' Bureau - Celgene; Incyte; Merck KGaA; SERVIER; Sirtex Medical
Research Funding - Merck KGaA (Inst); Merck Sharp & Dohme (Inst); Pfizer (Inst); Sirtex Medical (Inst)
 
Paul J. Ross
Stock and Other Ownership Interests - Perci Health
Honoraria - AstraZeneca; Merck; Roche; Sirtex Medical
Consulting or Advisory Role - Amgen; AstraZeneca; Boston Scientific; Roche; Sirtex Medical
Speakers' Bureau - Amgen; Boston Scientific; Eisai; Merck; Roche; Servier
Research Funding - Bayer (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Ipsen; Roche
 
Yuk Ting Ma
No Relationships to Disclose
 
Arvind Arora
No Relationships to Disclose
 
Stephen Falk
Stock and Other Ownership Interests - GlaxoSmithKline; Pfizer
Consulting or Advisory Role - BMS
Speakers' Bureau - Amgen; Merck Serono; Merck Serono; Merck Serono; SERVIER
Research Funding - AstraZeneca (Inst); Gilead Sciences (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Celgene
Other Relationship - SERVIER
 
Roopinder Gillmore
No Relationships to Disclose
 
Jonathan Wadsley
Consulting or Advisory Role - Bayer (Inst); Ipsen (Inst); Lilly (Inst); Novartis (Inst); Roche (Inst)
Speakers' Bureau - Eisai; Genzyme
Research Funding - AstraZeneca; Genzyme
 
Kinnari Patel
No Relationships to Disclose
 
Alan Anthoney
No Relationships to Disclose
 
Anthony Maraveyas
No Relationships to Disclose
 
Claire Hobbs
No Relationships to Disclose
 
Lorna Wilkinson
No Relationships to Disclose
 
Timothy Macdonald
No Relationships to Disclose
 
Claire Hartley
No Relationships to Disclose
 
David Ryder
No Relationships to Disclose
 
John A. Bridgewater
Honoraria - Incyte; SERVIER
Consulting or Advisory Role - AstraZeneca; Basilea; Bayer; Incyte; Merck Serono; Merck Serono; Roche; SERVIER; Taiho Oncology
Speakers' Bureau - Amgen; Bristol-Myers Squibb; Celgene
Research Funding - Amgen; Incyte (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Bristol-Myers Squibb/Medarex; Merck Serono; MSD Oncology; SERVIER
 
Juan W. Valle
Consulting or Advisory Role - Aptitude Health; AstraZeneca; Autem Medical; Baxter; Boehringer Ingelheim; Cantargia AB; Debiopharm Group; Genoscience Pharma; Hutchison MediPharma; Imaging Equipment Limited; Incyte; Ipsen; Keocyt; Medivir; Merck; Mundipharma; Novartis; Nucana; PCI Biotech; Pfizer; Pieris Pharmaceuticals; QED Therapeutics; SERVIER; Sirtex Medical; Taiho Oncology; Wren Laboratories; Zymeworks
Speakers' Bureau - Delcath Systems; Imaging Equipment Limited; Incyte; Ipsen; Mylan; Novartis; Nucana; SERVIER
Travel, Accommodations, Expenses - AstraZeneca/MedImmune; Lilly; Nucana; Roche